IMFL Growth Buried Under Margin Collapse — Profit Down 25% Despite Revenue Up 6%

A 6% revenue gain paired with a 25% profit decline is not a normal quarter — it is a margin crisis. Associated Alcohols delivered exactly this in Q1 FY-2027. The IMFL proprietary engine is working: ₹72.9 Cr revenue up 58% YoY, volume growth of 40%, and the CP Series brand surging 260% from 20,300 to 73,000 cases. Yet consolidated profit fell to ₹17.8 Cr, down ₹5.8 Cr YoY, and EBITDA margin contracted from 14% to 11% — a 3-percentage-point miss against the company's own 15% FY27 guidance. The culprit is not hard to find: ethanol losses of ₹5–6 per liter, grain prices at ₹21,000/ton (up 10%+), and the near-complete collapse of the licensed spirits business.

The Q1 result sheet masks three distinct profit drains: Ethanol segment losses of ₹5–6 per liter. The company is incurring ₹57–58/L to produce ethanol but selling it to private oil marketing companies (Reliance, Nayara, etc.) at only ₹52–54/L. Volume grew 28% YoY, but the realization cliff wiped out the top-line gain. Management says it is running the plant for government subsidies and interest subventions tied to capacity utilisation, and to cover fixed costs. The October government tender outcome will determine whether realisations improve, but there is no visible hedge in place if allocations remain low. Grain price inflation of 10%+, with maize and millet at ₹21,000/ton. This hits both the ENA business (volume +35%, but margin compressed) and raw material costs for the entire portfolio. IMFL proprietary margin fell from 22% to 20% despite 58% revenue growth — a sign that input cost growth is outpacing price realisation. Licensed business revenue halved. Inbrew, a major licensing contributor, shifted from licensing to contract manufacturing mid-Q2 FY26. Diageo revenue was flat. The company now expects only ₹100M+ annually in steady-state licensed revenue, down from a prior higher run-rate. This represents a one-time loss of revenue diversification and signals a strategic pivot entirely toward proprietary brands and new launches.

The post-result price action confirms the market's skepticism. The stock fell 3.62% on day 1, and by day 5 had declined 7.09% cumulatively. The market had priced in some optimism before the result (closing day-before at ₹821.45); the sell-off reflected disappointment in the profit miss and the margin compression story. This is not a snap reaction that faded — the decline held, signaling real conviction that the quarter was a miss, not a recovery.

The stock is down 40.23% from its all-time high of ₹1,277, now trading at ₹763.25 (as of 2026-07-31). It trades below all major averages: SMA20 of ₹809.15, SMA50 of ₹828.59, and SMA200 of ₹880.24. The drawdown is material and the technicals are weak. From the 52-week low of ₹663, the stock is up 15.12%, which suggests some recovery from panic, but the broader trend remains bearish.

Institutional ownership has collapsed. FII holdings have declined from 1.20% (FY2025 Q3) to 0.33% (FY2026 Q4 latest), a cumulative exit of 87 basis points. DII holdings are negligible (0.94% latest). This is not a flight-to-safety move; it is a de-rating of the stock by institutions who believed in the franchise and have since trimmed to minimal levels. Promoter ownership remains stable at 62.35%, suggesting no insider selling pressure, but the withdrawal of institutional capital is a red flag for momentum.

The fundamental story and the market action align: the profit collapse, the margin miss, and the unproven new launches have convinced the institutional base to step back. The stock's 40% drawdown from its all-time high is not noise — it is a repricing of risk and a loss of conviction in near-term earnings recovery.